Clinical experiences with 6-monthly paliperidone palmitate after 12 months of use. A retrospective study

INTRODUCTION: Long-acting injectable antipsychotics (LAIA) have provided a significant improvement in the treatment of schizophrenia. Although there is already significant clinical experience with paliperidone palmitate, it is important to evaluate the clinical response of patients to this new 6-mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Benavente López, S., Parra González, A., Bolaño Mendoza, S., Lara Fernández, A., Herencias Nevado, A., Baca García, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405681/
http://dx.doi.org/10.1192/j.eurpsy.2023.1043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405681/
http://dx.doi.org/10.1192/j.eurpsy.2023.1043

Ejemplares similares